Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

CUPERTINO, Calif., Dec. 11, 2023 -- Reviva Pharmaceuticals Holdings, Inc. , a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of...

Related Keywords

United States ,John Vandermosten ,Bruce Mackle ,Reviva Pharmaceuticals ,Cap Research ,Nasdaq ,Lifesci Advisors ,Securities Exchange ,Globenewswire Inc ,Reviva Pharmaceuticals Holdings Inc ,Exchange Commission ,Life Sciences Investor Forum ,Pharmaceuticals Holdings ,Sciences Investor Forum ,Senior Biotechnology Analyst ,Orphan Drug Designation ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Relations Contact ,Sci Advisors ,Markets ,